TNF and obesity disorder: Furthermore, empagliflozin reduced M1-polarized macrophage accumulation while inducing the anti-inflammatory M2 phenotype of macrophages within white adipose tissue and liver, lowering plasma TNFα levels and attenuating obesity-related chronic inflammation [45].